See also stories tagged with Drug discovery
Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or long-term lung damage. That scarring creates an environment that suppresses nearby immune cells, ...
A cell's ability to repair its damaged DNA is one of the most fundamental processes in biology, helping protect us from diseases like cancer. Over the years, researchers have unraveled many of the mechanisms cells use to ...
AI-predicted protein complex structures for more than 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritizes proteomes from viral ...
Across every cell in the body, molecules are constantly pulling, gripping and releasing under mechanical strain. That force often decides whether a drug sticks to its target, whether a cell holds its shape or whether a disease ...
Tuberculosis, or TB, is a contagious bacterial infection that primarily affects the lungs. While curative treatments exist, more than 80% of cases occur in low- and middle-income nations, where drug-resistant strains are ...
Misophonia causes strong emotions in response to everyday sounds like chewing or sniffing. The condition often involves feelings of immediate distress or anger. This can be confusing and upsetting for children, adults and ...
New York University researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where their hydrogen atoms should be positioned.
Swimming in the blood, sweat, cells and tears of every human are small proteins known as peptides. Many peptides can kill bacteria on contact, yet the bacteria never seem to evolve resistance to them. Mass-produced peptides ...
Mitochondria—tiny structures that convert nutrients into energy—are often depicted as discrete kidney bean-shaped objects. But in reality, they form a dynamic, interconnected network throughout the entire cell, rapidly splitting ...
Brian Druker, M.D., has pretty much done it all as a pioneer in precision medicine. He developed a drug that turned chronic myeloid leukemia from a death sentence into a manageable condition; his discovery spurred the development ...
